The 2 analysts offering 12-month price forecasts for Aptevo Therapeutics Inc have a median target of 7.38, with a high estimate of 10.00 and a low estimate of 4.75. The median estimate represents a +3,701.55% increase from the last price of 0.19.
The current consensus among 2 polled investment analysts is to Buy stock in Aptevo Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.21
Reporting Date Mar 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.